Design Therapeutics, Inc. announced the initiation of a Phase 1 clinical trial for its gene-targeted treatment DT-216P2 in healthy volunteers, with patient dosing for Friedreich Ataxia (FA) set to ...

Forbes contributors publish independent expert analyses and insights. Jamie Gold writes about wellness design and related housing topics. Accessibility, one of bathroom design's top trends, is ...